After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration ...
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The FDA approved the sale of Zyn nicotine pouches, which are increasingly popular with teens. But nicotine pouches cause addiction, as smoking and vaping also do.
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
The Trump Administration is calling for a report “assess[ing] the prevalence of and threat" of several drugs, including stimulants like Adderall ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...